---

---

tags : Trials   

save search

---

Two Clinical Trials Identify a Better Way to Target Appropriate Antibiotics for Patients Hospitalized With Pneumonia or Urinary Tract Infection
Published: 2024-04-19 (Just crawled : 22:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320 |

Communications

| Email alert Add to watchlist
infection antibiotics trials for

---

Clinical Trials Matching Software Market Projected to Reach $832.56 million by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 04:00) - prnewswire.com
IBM | $181.58 0.06% -0.32% 3M |

Technology Services

| 0.0% | O: -0.17% H: 0.0% C: 0.0%
report million software reach trials market

---

SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR's SyMRI NEURO Software at SimonMed Facilities
Published: 2024-04-17 (Crawled : 09:00) - prnewswire.com
PHG | $19.98 0.0% 540K |

Health Technology

| -1.32% | O: -2.01% H: 1.0% C: 0.7%
software expansion trials

---

Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| -0.68% | O: -0.64% H: 0.45% C: -0.04%
million series trials program

---

Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
RVPH | $3.035 0.5% 0.49% 140K |

| -18.16% | O: -7.05% H: 4.96% C: 1.46%
fda brilaroxazine trials for schizophrenia

---

Kraig Biocraft Laboratories Announces Successful Launch of Spring Production Trials in Southeast Asia for Spider Silk
Published: 2024-04-15 (Crawled : 11:00) - globenewswire.com
KBLB | $0.088 -0.63% 350K |

Mining, Quarrying, and Oil and ...

| 9.42% | O: 3.95% H: 8.77% C: 0.76%
trials spring for asia

---

Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency
Published: 2024-04-08 (Crawled : 11:00) - globenewswire.com
INZY | $4.5 -1.75% -1.78% 590K |

Health Technology

| -27.99% | O: 2.2% H: 7.69% C: -9.69%
inz-701 pharma positive ongoing trials topline

---

Contineum Dials Back Plans with $110M IPO to Fund Neuroinflammatory Trials
Published: 2024-04-05 (Crawled : 14:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -6.72% | O: -1.84% H: 0.0% C: 0.0%
neuroinflammatory back trials

---

Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
NTRA S | $85.275 -2.3% -2.35% 2.5M |

Health Services

| -1.24% | O: -0.6% H: 2.8% C: 2.25%
cancer trials trial

---

Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Published: 2024-03-27 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -7.26% | O: -0.26% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -7.5% | O: 1.06% H: 0.0% C: 0.0%
MRNA S | $101.44 -0.55% -0.55% 2.6M |

Health Technology

| -3.7% | O: 2.02% H: 1.41% C: 0.92%
vaccine trials

---

Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024
Published: 2024-03-26 (Crawled : 12:30) - globenewswire.com
INZY | $4.5 -1.75% -1.78% 590K |

Health Technology

| -26.48% | O: 2.09% H: 14.47% C: 6.6%
inz-701 pharma report ongoing trials topline

---

Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
Published: 2024-03-25 (Crawled : 13:00) - globenewswire.com
SAVA | $19.61 -7.46% -8.06% 1.3M |

Health Technology

| 7.37% | O: 3.43% H: 2.0% C: -3.86%
review trials sciences

---

Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials
Published: 2024-03-20 (Crawled : 11:00) - prnewswire.com
LH M | $201.48 1.02% 0.0% 770K |

Health Services

| -5.21% | O: -0.32% H: 0.29% C: -0.45%
disease test biomarker blood trials alzheimer's

---

Kraig Biocraft Laboratories Brings Leading Sericulture Expert from India for Launch of Spring Production Trials
Published: 2024-03-19 (Crawled : 11:00) - globenewswire.com
KBLB | $0.088 -0.63% 350K |

Mining, Quarrying, and Oil and ...

| 2.04% | O: 0.0% H: 9.41% C: 2.83%
india trials spring

---

Clinical Trials Market Size and Global Forecast Report 2024: Industry Trends, Share, Growth, Insight, Company Analysis 2023-2030
Published: 2024-03-13 (Crawled : 15:30) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.85% | O: -0.04% H: 0.0% C: 0.0%
ICLR | $288.32 -1.2% -1.21% 640K |

Health Technology

| -13.7% | O: 0.61% H: 0.16% C: -2.04%
company report trials global market

---

Merck Announces Plans to Conduct Clinical Trials of a Novel Investigational Multi-Valent Human Papillomavirus (HPV) Vaccine and Single-Dose Regimen for GARDASIL®9
Published: 2024-03-13 (Crawled : 11:00) - biospace.com/
MRK | $125.78 0.44% 0.0% 8.4M |

Health Technology

| 2.21% | O: 0.41% H: 0.04% C: -0.81%
gardasil vaccine merck trials

---

Global Bispecific Antibody Market Clinical Trials Insight Report to 2029: 12 Bispecific Antibodies Generated Revenue of Over US$ 8.5 Billion in 2023
Published: 2024-03-13 (Crawled : 03:00) - prnewswire.com
IMAB | $1.81 0.56% 0.55% 340K |

Health Technology

| -1.64% | O: 3.28% H: 2.65% C: -2.65%
report antibody revenue trials global market

---

Kraig Biocraft Laboratories Senior Management travels to Vietnam for Launch of Spring Trials
Published: 2024-03-12 (Crawled : 11:00) - globenewswire.com
KBLB | $0.088 -0.63% 350K |

Mining, Quarrying, and Oil and ...

| -9.55% | O: 3.02% H: 8.1% C: -12.2%
management trials spring

---

Asha Therapeutics to Present at AD/PD™ 2024 International Conference and Announces Clinical Development Plan for Lead Programs Anticipated to Enter Clinical Trials this Year and Welcomes Two New SAB Members
Published: 2024-03-08 (Crawled : 15:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -9.42% | O: -0.68% H: 0.0% C: 0.0%
conference year international trials therapeutics

---

Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
Published: 2024-03-07 (Crawled : 11:00) - globenewswire.com
IMRN | $2.32 -5.31% -5.6% 26K |

Health Technology

| 46.05% | O: 104.23% H: 76.85% C: 35.01%
travelan positive trials results

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | News | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---